Consensus conference definitions for sepsis, septic shock, acute lung injury, and acute respiratory distress syndrome: Time for a reevaluation

Critical Care Medicine

Volumn 28, Issue 1, 2000, Pages 232-235

  Abraham, Edward ^a   Matthay, Michael A ^c   Dinarello, Charles A ^b   Vincent, Jean Louis ^d   Cohen, Jonathan ^e   Opal, Steven M ^f   Glauser, Michel ^g   Parsons, Polly ^a   Fisher Jr , Charles J ^h   Repine, John E ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d ERASME HOSPITAL   (Belgium)

^e HAMMERSMITH HOSPITAL   (United Kingdom)

^f BROWN UNIVERSITY   (United States)

^g LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^h LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Acute lung injury; Acute respiratory distress syndrome (ARDS); Consensus conference; Cytokines; Definitions; Endotoxin; Infection; Organ dysfunction; Sepsis; Septic shock; Tumor necrosis factor

Indexed keywords

ACTIVATED PROTEIN C; ANTIINFLAMMATORY AGENT; COLLAGEN; CYTOKINE; ENDOTOXIN; HYPERTENSIVE AGENT; INOTROPIC AGENT; MONOCLONAL ANTIBODY; PROCOLLAGEN; PROSTAGLANDIN SYNTHASE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CLINICAL TRIAL; HUMAN; LUNG INJURY; NONHUMAN; ORGANIZATION; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME; SEPSIS; SEPTIC SHOCK; STANDARDIZATION; SYNDROME; THORAX RADIOGRAPHY; TIDAL VOLUME;

EID: 0004885790     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-200001000-00039     Document Type: Article

References (29)

1. 1. McCloskey RV, Straube RC, Sanders C, et al: Treatment of septic shock with human monoclonal antibody HA-1A.Ann Intern Med 1994; 121:1-5
2. 2. Abraham E, Anzueto A, Gutierrez G, et al: Monoclonal antibody to human tumor necrosis factor alpha (TNF Mab) in the treatment of patients with septic shock: A multi-center, placebo controlled, randomized, double-blind clinical trial. Lancet 1998; 351:929-933
3. 3. Abraham E, Glauser MP, Butler T, et al: p55 tumor necrosis factor receptor fusion protein in the treatment of patients with severe sepsis and septic shock. JAMA 1997; 277: 1531-1534
4. 4. Opal SM, Fisher CJ, Dhainaut J-FA, et al: Confirmatory interleukin-1 receptor antagonist trial in severe sepsis. Crit Care Med 1997; 25:1115-1124
5. 5. Bernard GR, Wheeler AP, Russell JA, et al: The effects of ibuprofen on the physiology and survival of patients with sepsis. N Engl J Med 1997; 336:912-918
6. 6. Bone RC, Balk RA, Cerra FB, et al: ACCP/ SCCM consensus conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992; 101:1644-1655
7. 7. Bernard GR, Artigas A, Brigham KL, et al: The American-European consensus conference on ARDS: Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994; 149: 818-824
8. 8. Zeni F, Freeman B, Natanson C: Antiinflammatory therapies to treat sepsis and septic shock: A reassessment. Crit Care Med 1997; 25:1095-1100
9. 9. Kollef MH, Schuster DP: The acute respiratory distress syndrome. N Engl J Med 1995; 332:27-37
10. 10. Bone RC, Grodzin CJ, Balk RA: Sepsis: A new hypothesis for pathogenesis of the disease process. Chest 1997; 112:235-243
11. 11. Abraham E: Emerging therapies for sepsis and septic shock. West J Med 1997; 166:195-200
12. 12. Folkesson HG, Matthay MA, Hebert CA, et al: Acid aspiration-induced lung injury in rabbits is mediated by interleukin-8 dependent mechanisms. J Clin Invest 1995; 96:107-116
13. 13. Pittet JF, Mackersie RC, Martin TR, et al: Biological markers of acute lung injury: Prognostic and pathogenetic significance. Am J Respir Crit Care Med 1997; 155:1187-1205
14. 14. Wiener-Kronish JP, Sakuma T, Kudoh I, et al: Alveolar epithelial injury and pleural empyema in acute P. aeruginosa pneumonia in anesthetized rabbits. J Appl Physiol 1993; 75:1661-1669
15. 15. Connelly K, Repine JE: Markers for predicting the development of acute respiratory distress syndrome. Annu Rev Med 1997; 48:429-445
16. 16. Moss M, Bucher B, Moore FA, et al: Predicting the development of the adult respiratory distress syndrome: The role of chronic alcohol abuse. JAMA 1996; 275:50-54
17. 17. Moss M, Steinberg K, Guidot D, et al: Diabetic patients with septic shock have a decreased incidence of the acute respiratory distress syndrome (ARDS). Am J Respir Crit Care Med 1997; 155:A503
18. 18. Moss M, Gillespie M, Ackerson L, et al: Endothelial cell activity varies in patients at risk for the adult respiratory distress syndrome. Crit Care Med 1996; 24:1782-1786
19. 19. Parsons P, Worthen G, Moore E, et al: The association of circulating endotoxin with the development of the adult respiratory distress syndrome. Am Rev Respir Dis 1989; 140: 294-301
20. 20. Donnelly TJ, Meade P, Jagels M, et al: Cytokine, complement and endotoxin profiles associated with the development of the adult respiratory distress syndrome following injury. Crit Care Med 1994; 22:768-776
21. 21. Hoffman SL, Punjabi NH, Kumala S, et al: Reduction of mortality in chloramphenicol-treated severe typhoid fever by high-dose dexamethasone. N Engl J Med 1984; 310:82-88
22. 22. Chesnutt AN, Matthay MA, Tibayan F, et al: Early detection of type III procollagen peptide in acute lung injury: Pathogenetic and prognostic significance. Am J Respir Crit Care Med 1997; 156:840-845
23. 23. Rubin D, Wiener-Kronish JP, Murray JF, et al: Elevated von Willebrand factor antigen is an early plasma predictor of acute lung injury in nonpulmonary sepsis syndrome. J Clin Invest 1990; 86:474-480
24. 24. Doyle RL, Szaflarski N, Modin GW, et al: Identification of patients with acute lung injury: Predictors of mortality. Am J Respir Crit Care Med 1995; 152:1818-1824
25. 25. Zanetti G, Heumann D, Gerain J, et al: Cytokine production after intravenous or peritoneal Gram-negative bacterial challenge in mice. J Immunol 1992; 148:1890-1897
26. 26. Fisher CJ Jr, Agosti JM, Opal SM, et al: Treatment of septic shock with the tumor necrosis factor receptor Fc fusion protein. N Engl J Med 1996; 334:1697-1702
27. 27. James EA, Schmeltzer K, Ligler FS: Detection of endotoxin using an evanescent wave fiber-optic biosensor. Appl Biochem Biotechnol 1996; 60:189-202
28. 28. Berkova N, Karawajew L, Korobko V, et al: Development of an enzyme immunoassay for the measurement of human tumor necrosis factor α (hTNF-α) using biospecific antibodies to hTNF-α and horseradish peroxidase. Biotechnol Appl Biochem 1996; 23:163-171
29. 29. Giroir BP, Quint PA, Barton P, et at. Preliminary evaluation of recombinant amino-terminal fragment of bactericidal/permeability-increasing protein in children with severe meningococcal sepsis. Lancet 1997; 350: 1439-1443